Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -1.303% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] c1ccc(Cn2cc(CN3CCCCO3)c(-c3ccc4c(c3)OCO4)n2)cc1
[b] COc1cc(CN2CCNC(=O)C2CC(=O)NC2CCC2)cc(OC)c1
Answer: a. c1ccc(Cn2cc(CN3CCCCO3)c(-c3ccc4c(c3)OCO4)n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(Cn2cc(CN3CCCCO3)c(-c3ccc4c(c3)OCO4)n2)cc1
c1ccc(Cn2cc(CN3CCCCO3)c(-c3ccc4c(c3)OCO4)n2)cc1
2-[[3-(1,3-benzodioxol-5-yl)-1-benzylpyrazol-4-yl]methyl]oxazinane